News

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, acknowledges that the ...
Roche’s move came against a backdrop of wider industry retreat from gene therapy, with Pfizer pulling its FDA-approved ...
Most Americans encounter the Federal Trade Commission only if they’ve been scammed: It handles identity theft, fraud, and ...
The European Medicines Agency determined testing failed to prove Elevidys’ benefit and issued a negative opinion that could ...